SUTRO BIOPHARMA, INC. - STRO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Perceptive Advisors LLC 7.9% 1,304,846 View
Aug 14, 2026 SCHEDULE 13G/A Joseph Edelman 7.9% 1,304,846 View
Aug 14, 2026 SCHEDULE 13G/A Perceptive Life Sciences Master Fund, Ltd. 7.9% 1,304,846 View
Aug 14, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 1.4% 237,827 View
Aug 14, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 1.4% 237,827 View
Aug 14, 2026 SCHEDULE 13G/A Steven A. Cohen 1.4% 237,827 View
May 15, 2026 SCHEDULE 13G Samsara BioCapital, L.P. 2.5% 419,095 View
May 15, 2026 SCHEDULE 13G Samsara BioCapital GP, LLC 2.5% 419,095 View
May 15, 2026 SCHEDULE 13G Samsara Opportunity Fund, L.P. 3.9% 643,777 View
May 15, 2026 SCHEDULE 13G Samsara Opportunity Fund GP, LLC 3.9% 643,777 View
May 15, 2026 SCHEDULE 13G Srinivas Akkaraju 6.4% 1,062,872 View
May 15, 2026 SCHEDULE 13G/A Kynam Capital Management, LP 5.27% 0 View
May 15, 2026 SCHEDULE 13G/A Kynam Capital Management GP, LLC 5.27% 0 View
May 15, 2026 SCHEDULE 13G/A Yue Tang 5.27% 0 View
May 14, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 6.5% 1,069,519 View
May 14, 2026 SCHEDULE 13G/A Michael Cho 6.5% 1,069,519 View
May 01, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.7% 946,829 View
May 01, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.7% 946,829 View
May 01, 2026 SCHEDULE 13G Steven A. Cohen 5.7% 946,829 View
Apr 21, 2026 SCHEDULE 13G/A Millennium Management LLC 1.3% 210,378 View
Apr 21, 2026 SCHEDULE 13G/A Millennium Group Management LLC 1.3% 210,378 View
Apr 21, 2026 SCHEDULE 13G/A Israel A. Englander 1.3% 210,378 View
Apr 21, 2026 SCHEDULE 13G Perceptive Advisors LLC 5.4% 898,025 View
Apr 21, 2026 SCHEDULE 13G Joseph Edelman 5.4% 898,025 View
Apr 21, 2026 SCHEDULE 13G Perceptive Life Sciences Master Fund, Ltd. 5.4% 898,025 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.